Skip to main content
. 2023 Jun 28;12:e83764. doi: 10.7554/eLife.83764

Table 2. Cancellations and postponements of cervical cancer screening appointments.

Question number and content (number of responses) Categories n (%)
Q6 Cancellations of screening appointments (n=510) Yes 325 (63.7)
No 114 (22.4)
Don’t know 39 (7.7)
Not applicable to my practice 32 (6.3)
Q7 Percentage of cancelled screening appointments (n=325) Cancelled by physician or provider’s institution 0% 37 (11.4)
1–24% 107 (32.9)
25–49% 74 (22.8)
50–74% 53 (16.3)
≥75% 35 (10.8)
Don’t know 19 (5.8)
Cancelled by patient 0% 8 (2.5)
1–24% 124 (38.2)
25–49% 83 (25.5)
50–74% 44 (13.5)
≥75% 42 (12.9)
Don’t know 24 (7.4)
Converted to telemedicine 0% 77 (23.7)
1–24% 88 (27.1)
25–49% 44 (13.5)
50–74% 56 (17.2)
≥75% 36 (11.1)
Don’t know 24 (7.4)
Q8 Postponements of screening practices (n=510) Yes 382 (74.9)
No 73 (14.3)
Don’t know 24 (4.7)
Not applicable to my practice 31 (6.1)
Q9 Percentage of postponed screening appointments (n=382) Postponed by physician or provider’s institution 0% 40 (10.5)
1–24% 110 (28.8)
25–49% 87 (22.8)
50–74% 66 (17.3)
≥75% 54 (14.1)
Don’t know 25 (6.6)
Postponed by patient 0% 12 (3.1)
1–24% 153 (40.1)
25–49% 108 (28.3)
50–74% 46 (12.0)
≥75% 33 (8.7)
Don’t know 30 (7.9)
Converted to telemedicine 0% 103 (27.0)
1–24% 104 (27.2)
25–49% 60 (15.7)
50–74% 53 (13.9)
≥75% 29 (7.6)
Don’t know 33 (8.6)
Q10 Length of deferral period for postponed screening appointments (n=382) 1 week to <2 weeks 15 (3.9)
2 weeks to <4 weeks 47 (12.3)
1 month to <2 months 66 (17.3)
2 months to <4 months 118 (30.9)
4 months to <6 months 78 (20.4)
>6 months 36 (9.4)
Don’t know 22 (5.7)